首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation.
【24h】

Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation.

机译:日本患者的雌激素受体基因多态性和多发性硬化症:与HLA-DRB1 * 1501的相互作用和疾病调节。

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated PvuII and XbaI polymorphism in the estrogen receptor gene (ERG) and HLA-DRB1*1501 positivity in 116 conventional multiple sclerosis (MS) patients and 101 healthy controls in a Japanese population. Logistic analysis revealed independent associations of [P] allele in the profiles for PvuII (p=0.0005, adjusted odds ratio (aOR)=3.17) and DRB1*1501 (p=0.0089, aOR=2.61) with conventional MS. Synergistic elevated risk of MS due to interaction between the [P] allele and HLA-DRB1*1501 allele was found among female patients (odds ratio=16.0; 95% CI=3.99-63.8, p<0.0001). The [P] allele-positive patients with disease duration of more than 5 years had a significantly higher progression index (PI) of disability (p=0.0230) and a worse ranked MS severity score (p=0.0152) than their non-[P] counterparts.
机译:我们调查了日本人群中116例常规多发性硬化症(MS)患者和101例健康对照者的雌激素受体基因(ERG)和HLA-DRB1 * 1501阳性的PvuII和XbaI多态性。 Logistic分析显示,PvuII(p = 0.0005,调整后的优势比(aOR)= 3.17)和DRB1 * 1501(p = 0.0089,aOR = 2.61)与常规MS的谱中[P]等位基因具有独立关联。在女性患者中发现由于[P]等位基因与HLA-DRB1 * 1501等位基因之间的相互作用而协同增发MS的风险(优势比= 16.0; 95%CI = 3.99-63.8,p <0.0001)。疾病持续时间超过5年的[P]等位基因阳性患者的残疾进展指数(PI)显着高于非P等级(p = 0.0230),而MS严重程度评分(p = 0.0152)更差]同行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号